Published on
August 16, 2019
- 11:00 GMT
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO®
TORONTO, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market TULSA-PRO® for ablation …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Media, Advertising & PR
...
